We are international
Donate
publications TEXT SIZE   
the understanding series    back

IMF LOOKS FORWARD TO RAPID REVIEW OF REVLIMID FOR MYELOMA PATIENTS FOLLOWING FDA APPROVAL FOR MDS
12.28.05

Be the first to comment

 related articles